PubRank

Angela Sciacqua

Author PubWeight™ 44.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J Am Coll Cardiol 2003 1.67
2 Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 2005 1.38
3 Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005 1.33
4 Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res 2004 1.28
5 Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care 2012 1.16
6 Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation 2010 1.14
7 Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension. Diabetes 2007 1.10
8 One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol 2010 1.08
9 The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes 2004 1.05
10 Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. Int J Cardiol 2009 1.02
11 Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 2011 1.01
12 Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. Diabetes Care 2012 0.99
13 Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells. Mol Cell Biol 2007 0.95
14 Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. Acta Diabetol 2013 0.94
15 The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. Diabetes Care 2004 0.93
16 Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2013 0.93
17 A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep 2013 0.90
18 Serum uric acid and 1-h postload glucose in essential hypertension. Diabetes Care 2011 0.90
19 Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients. Int J Cardiol 2012 0.88
20 Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects. Am J Cardiol 2011 0.87
21 Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women. Eur J Cardiovasc Prev Rehabil 2009 0.86
22 Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) 2011 0.86
23 Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects. Eur J Endocrinol 2010 0.86
24 Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects. Diabetes Care 2008 0.85
25 Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold. Diabetes Metab Res Rev 2007 0.83
26 Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs. Atherosclerosis 2011 0.83
27 Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients. J Hypertens 2009 0.83
28 Impaired endothelial function in never-treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate-1 gene. J Clin Endocrinol Metab 2004 0.82
29 Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension. J Nephrol 2007 0.82
30 Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol 2014 0.81
31 A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. PLoS One 2012 0.81
32 Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels. PLoS One 2013 0.81
33 Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study. Pharmacogenomics 2014 0.81
34 Low insulin-like growth factor-1 levels are associated with anaemia in adult non-diabetic subjects. Thromb Haemost 2010 0.80
35 Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. Diabetes Metab Res Rev 2009 0.80
36 Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. J Hypertens 2007 0.80
37 Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients. Clin J Am Soc Nephrol 2010 0.79
38 Gly460Trp alpha-adducin gene polymorphism and endothelial function in untreated hypertensive patients. J Hypertens 2007 0.79
39 Endothelial dysfunction predicts regression of hypertensive cardiac mass. Int J Cardiol 2012 0.79
40 Vitamin D and 1-hour post-load plasma glucose in hypertensive patients. Cardiovasc Diabetol 2014 0.79
41 Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs. Cardiovasc Res 2013 0.78
42 Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation. Nutr Metab Cardiovasc Dis 2006 0.78
43 Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. J Clin Endocrinol Metab 2008 0.78
44 One-hour post-load plasma glucose and IGF-1 in hypertensive patients. Eur J Clin Invest 2012 0.78
45 Oxidative stress impairs endothelial function in nondipper hypertensive patients. Cardiovasc Ther 2010 0.78
46 Relation of fasting insulin related to insertion/deletion polymorphism of angiotensin-converting enzyme-gene and cardiac mass in never-treated patients with systemic hypertension. Am J Cardiol 2003 0.77
47 Phenotypic characterization of normotolerant hypertensive patients. Int J Cardiol 2011 0.77
48 A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease. Atherosclerosis 2013 0.75
49 Low dose of acetylsalicylic acid and oxidative stress-mediated endothelial dysfunction in diabetes: a short-term evaluation. Acta Diabetol 2014 0.75
50 Serum alkaline phosphatase negatively affects endothelium-dependent vasodilation in naïve hypertensive patients. Hypertension 2015 0.75
51 Insulin clearance is associated with carotid artery intima-media thickness. Atherosclerosis 2013 0.75
52 Creatinine and insulin predict cardiac mass in drug-naïve hypertensive patients. Int J Cardiol 2012 0.75
53 Heart rate affects endothelial function in essential hypertension. Intern Emerg Med 2011 0.75
54 Multiplicative effect of serum phosphorus levels and insulin resistance on hypertensive vascular stiffness. Thromb Haemost 2015 0.75